+33(0)1 42 54 60 64 | contact@welcomeurope.com

IMI-ECSEL – Joint Activity complementing the Trials@Home project – 2020

Improving the drug development process by supporting research and development cooperation between academia, SMEs and the biopharmaceutical industry

2020-09-30
5 million euros
Close

Appeal framework

Institution European Commission
Sectors Health
Beneficiaries
Regions European Union, European Economic Area, Switzerland, Caucasus
Details

EU Member States
EEA countries
Switzerland
Turkey


Content reserved for subscribers

Register for free to access the content

Free access to all information

Priorities and funded actions

Objectives
* To start for the running IMI JU project (Trails@Home) and complement to and extent on the technology scan activity of the project which will identify barriers, enablers and data management for the Remore Decentralised Clinical Trials

Additional information
* This call for proposals is an open call for proposals

* Initial duration of the action: up to 3 years

* Eligibility:
– At least three legal entities. Each of the three must be established in a different Member State or associated country;
– All three legal entities must be independent of each other

 

Financement

* Grant amount: 5 million euros

* Co-financing rate: between 25% and 35% of the total eligible costs depending on the type of applicant

Test your eligibility

Other funds:

Aucune relation trouvée.

Similar news

25 August 2021

Webinar Horizon Europe: Guide to prepare an accurate financial statement on time

Read the article

9 June 2021

Welcomeurope’s new service!

Read the article